, Volume 23, Issue 9, pp 926-929

Who Benefits from Portal Vein Resection during Pancreaticoduodenectomy for Pancreatic Cancer?

Rent the article at a discount

Rent now

* Final gross prices may vary according to local VAT.

Get Access


Portal vein resection during pancreaticoduodenectomy has recently experienced renewed interest. We describe our results with this procedure over a 20-year period. Among 88 consecutive pancreatectomies for cancer of head of the pancreas, 14 included en bloc removal of the portal vein. There was no hospital mortality. Only 21% were found to have histologically confirmed cancer invasion, and the remainder had inflammatory adherence. Two-year survival was 15% compared to 34% for patients who did not have portal vein resection. There were no 5-year survivors. We discuss our results in light of other recent reports.